Stefan Florian

Stefan Florian

Auto-generated profile, based on publicly available information

Stefan Florian

Institute of Pathology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2025 in Cancer Research
Verified
Journal Article
Closed access
FPFlaminia Pedretti
Flaminia Pedretti
Mohamed Abdel-FattahMohamed Abdel-Fattah
Mohamed Abdel-Fattah
BPBenedetta Pellegrino
Benedetta Pellegrino
FMFrancesca Mateo
Francesca Mateo
PSPaula Martinez Sanz
Paula Martinez Sanz
VSVioleta Serra
Violeta Serra
Homologous recombination deficiency (HRD) contributes to genomic instability and leads to sensitivity to PARP inhibitors (PARPi). HRD also activates the cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING)–interferon pathway, highlighting the need to understand the impact of cGAS–STING–IFN signaling on PARPi efficacy. In this study, we analyzed a cohort of 35 breast cancer patient-derived xenografts and mouse-derived allografts. PARPi sensitivity correlated with HRD, increased genomic instability, and activation of the cGAS–STING–IFN signaling pathway. Single-cell analyses showed that IFN signaling and IFN-based immune interactions were suppressed in preclinical models with acquired resistance to PARPi, lacking concomitant clonal expansion of functional CD8+ T cells. However, the combination of a PARPi and a novel STING agonist (STINGa) increased immune infiltration and resulted in superior antitumor activity in these tumors. Notably, the efficacy of PARPi monotherapy and the combination treatment with a STINGa was dependent on natural killer (NK) cells. In agreement, patients with breast cancer with BRCA1/BRCA2 mutations and good responses to PARPi showed higher abundancy of CD56+ NK cells in the tumor microenvironment and treatment-engaged CD56bright NK cells in the peripheral immune compartment, compared with those with poor responses. Therefore, these findings propose the combination of PARPis and a STINGa as a potential novel strategy to enhance the therapeutic response in patients with acquired PARPi resistance and highlight a pivotal role of NK cells in the PARPi antitumor activity. Significance: PARP inhibitor sensitivity is associated with cGAS–STING–IFN signaling, which can be harnessed by combining PARP inhibitors with STING agonists to overcome acquired resistance and requires NK cells to mediate antitumor immunity. See related commentary by Gohari et al., p. 1747

17 May 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SFStefan Florian
Stefan Florian
YIYoshiko Iwamoto
Yoshiko Iwamoto
MCMargaret Coughlin
Margaret Coughlin
RWRalph Weissleder
Ralph Weissleder
TMTimothy J. Mitchison
Timothy J. Mitchison
Significance: Organoid culture allows the study of tissue function and development in vitro. Here, we show that mammary cells can autonomously reassemble in vitro to form a common benign mammary lesion [usual ductal hyperplasia (UDH)]. Currently, very little is known about how UDH develops. In vitro, we observe a coordinated process reminiscent of embryonic development of the mammary gland that recapitulates typical morphological hallmarks of UDH at all stages, suggesting that, in vivo, such lesions also form through the same sequence of events. Thus, we speculate that UDH lesions form through activation of embryonic-like developmental programs in adult mammary cells. The culture protocols introduced here will be useful to study supracellular coordination of mammary cell behavior.

7 October 2011 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
GEGertraud Engl
Gertraud Engl
SFStefan Florian
Stefan Florian
LTLisbeth Tranebjærg
Lisbeth Tranebjærg
DRDoron Rapaport
Doron Rapaport
Deafness-Dystonia-Optic Neuropathy (DDON) Syndrome is a rare X-linked progressive neurodegenerative disorder resulting from mutations in the TIMM8A gene encoding for the deafness dystonia protein 1 (DDP1). Despite important progress in identifying and characterizing novel mutations in this gene, little is known about the underlying pathomechanisms. Deficiencies in the biogenesis of hTim23 and consecutive alterations in biogenesis of inner membrane and matrix proteins have been proposed to serve as one possible mechanistic explanation. To shed new light on the role of DDP1 in the biogenesis of mammalian mitochondria, we investigated the effects of reduced or elevated DDP1 levels on mitochondrial dynamics and function. Our results show a reduction in the import of β-barrel proteins into mitochondria from cells overexpressing DDP1. This effect was not observed when the DDON-related mutant form DDP1-C66W was overexpressed. Live cell microscopy of primary fibroblasts derived from DDON patients and of DDP1 downregulated HeLa cells displayed alterations of mitochondrial morphology with notable extensions in the length of mitochondrial tubules, whereas overexpression of DDP1 induced the formation of hollow spherical mitochondria. Of note, knockdown of the TIMM8A gene by RNA interference did not show an influence on the oxygen respiration rate and the mitochondrial membrane potential. Taken together, these results suggest that alterations in the levels of DDP1 can affect the morphology of mitochondria and thus shed new light on the pathogenic mechanisms of DDON.

1 February 2024 in Cellular Oncology
Verified
Journal Article
Open access
PDF file
ATAlexandra Trinks
Alexandra Trinks
MMMiha Milek
Miha Milek
DBDieter Beule
Dieter Beule
JKJulie Kluge
Julie Kluge
SFStefan Florian
Stefan Florian
PBPhilip Bischoff
Philip Bischoff
Purpose: Single-cell transcriptional profiling reveals cell heterogeneity and clinically relevant traits in intra-operatively collected patient-derived tissue. So far, single-cell studies have been constrained by the requirement for prospectively collected fresh or cryopreserved tissue. This limitation might be overcome by recent technical developments enabling single-cell analysis of FFPE tissue. Methods: We benchmark single-cell profiles from patient-matched fresh, cryopreserved and archival FFPE cancer tissue. Results: We find that fresh tissue and FFPE routine blocks can be employed for the robust detection of clinically relevant traits on the single-cell level. Specifically, single-cell maps of fresh patient tissues and corresponding FFPE tissue blocks could be integrated into common low-dimensional representations, and cell subtype clusters showed highly correlated transcriptional strengths of signaling pathway, hallmark, and clinically useful signatures, although expression of single genes varied due to technological differences. FFPE tissue blocks revealed higher cell diversity compared to fresh tissue. In contrast, single-cell profiling of cryopreserved tissue was prone to artifacts in the clinical setting. Conclusion: Our analysis highlights the potential of single-cell profiling in the analysis of retrospectively and prospectively collected archival pathology cohorts and increases the applicability in translational research.

1 October 2005 in International Archives of Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
MKMaria Theresa Krauth
Maria Theresa Krauth
YMYasamin Majlesi
Yasamin Majlesi
SFStefan Florian
Stefan Florian
ABAlexandra Böhm
Alexandra Böhm
AHAlexander W. Hauswirth
Alexander W. Hauswirth
Peter ValentPeter Valent
Peter Valent
Background: Mast cells (MC) are important effector cells of allergic and inflammatory reactions in diverse organs. These cells interact with a number of other immune cells and structural cells in the tissues as well as with proinflammatory mediators and cytokines. The various interactions are considered to be mediated through distinct cell surface membrane receptors on MC. Methods:In the present study, we have established the cell surface membrane phenotype of human gastrointestinal MC (HGMC) using a panel of monoclonal antibodies and indirect immunofluorescence staining techniques. Results: HGMC were found to react with antibodies against CD29, CD33, CD44, CD45, CD47, CD54, CD55, CD58, CD63, CD117, CD147, CD151, CD172a, and CD203c. By contrast, HGMC did not express detectable amounts of CD1, CD2, CD4, CD5, CD14, CD15, CD16, CD22, CD24, CD25, CD26, CD27, CD28, CD31, CD32, CD34, CD35, CD88, or CD116. The α-chain of the IL-3 receptor (CD123) was detectable neither in resting HGMC nor in HGMC exposed to stem cell factor and interleukin-4. Conclusions: HGMC express a unique profile of surface antigens including the receptor for mast cell growth factor, adhesion-related molecules, and activation-linked membrane antigens.

1 January 2008 in International Journal of Immunopathology and Pharmacology
Verified
Journal Article
Open access
KSK. Sonneck
K. Sonneck
Christian BaumgartnerChristian Baumgartner
Christian Baumgartner
LRL. Rebuzzi
L. Rebuzzi
KMK. Marth
K. Marth
KCKuan-Wei Chen
Kuan-Wei Chen
Peter ValentPeter Valent
Peter Valent
IgE-dependent activation of basophils is associated with upregulation of several surface molecules. We recently identified the surface enzyme aminopeptidase N (CD13) as a novel activation antigen on human basophils. In the present study, we asked whether CD13 can be employed as a novel marker of allergen-induced activation of basophils in allergic individuals. Patients allergic to major allergens from grass pollen (Phl p 1, Phl p 5), birch pollen (Bet v 1), or house dust mites (Der p 2), were examined. Blood basophils were exposed to various concentrations of recombinant allergens for 15 minutes, and examined for expression of CD13 by multicolor flow cytometry. The allergen-induced upregulation of CD13 was compared with allergen-dependent increases in expression of CD63 and CD203c. Exposure to recombinant allergens resulted in an increase in expression of CD13 on basophils in all sensitized individuals, whereas no increase in CD13 was seen in healthy controls. The effects of the recombinant allergens on CD13-expression were dose- and time-dependent, were not observed in the absence of extracellular calcium, and were counteracted by preincubation of basophils with the PI3-kinase-targeting drugs staurosporin and LY294002. There was a good correlation between allergen-induced upregulation of CD13, CD63, and CD203c on basophils. In aggregate, our data show that recombinant allergens promote expression of CD13 on basophils in sensitized individuals. The functional significance and diagnostic implications of this observation remain to be determined.